Panobinostat PK/PD profile in combination with bortezomib and dexamethasone in patients with relapsed and relapsed/refractory multiple myeloma

PURPOSE: Panobinostat, a potent pan-deacetylase inhibitor, improved progression-free survival (PFS) in patients with relapsed and refractory multiple myeloma when combined with bortezomib and dexamethasone in a phase 3 trial, PANORAMA-1. This study aims to explore exposure–response relationship for...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Eur J Clin Pharmacol
Autors principals: Mu, Song, Kuroda, Yoshiaki, Shibayama, Hirohiko, Hino, Masayuki, Tajima, Takeshi, Corrado, Claudia, Lin, Rong, Waldron, Edward, Binlich, Florence, Suzuki, Kenshi
Format: Artigo
Idioma:Inglês
Publicat: Springer Berlin Heidelberg 2015
Matèries:
Clinical Trial
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4713719/
https://ncbi.nlm.nih.gov/pubmed/26494130
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00228-015-1967-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars